- May 4, 2022
- 11:00 AM - 12:00 PM ET
- Organized By:
Overview of Cancer Moonshot:
On February 2, 2022, President Biden reignited the Cancer Moonshot and set new ambitious goals: to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and their families living with and surviving cancer — and, by doing this and more, end cancer as we know it today. President Biden announced a whole of government response, including the formation of a Cancer Cabinet to be convened by the White House, bringing together departments, agencies, and other White House components across government to address cancer on multiple fronts. For more information and to engage with the effort visit: whitehouse.gov/cancermoonshot
May 4 FDA Oncology Center of Excellence Community Conversation:
The FDA Oncology Center of Excellence will host a roundtable titled, "Moving on Equity: OCE Expands Diversity Initiative," as part of a series of coordinated Cancer Cabinet Community Conversations being held on May 4, 2022, under President Biden’s Cancer Moonshot Initiative. The OCE event will be held from 11 am – 12 pm on May 4. It will be open to the public for viewing on YouTube.
FDA’s roundtable conversation will focus on the new draft Guidance, "Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials." Various stakeholders in the oncology community will share their perspectives on the guidance and provide valuable feedback to the FDA as we organize around President Biden's priority to end cancer as we know it.
A free-of-charge webcast of this public panel discussion will be streamed live on Wednesday, May 4, 2022, from 11:00 am – 12:00 pm, and available on demand through the following link: https://www.youtube.com/watch?v=8k1BMF31fLU
For any inquiries regarding this event, please contact: OCE-Equity@fda.hhs.gov
|Cancer Moonshot Moving on Equity Panelist Bios||pdf (370.66 KB)|